Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Apr 27, 2024; 16(4): 1055-1065
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1055
Published online Apr 27, 2024. doi: 10.4240/wjgs.v16.i4.1055
Considerations | Transfer group (n = 52) | Non-transfer group (n = 190) | t/z/χ2 | P value |
SII | 385.21 ± 78.63 | 264.29 ± 64.43 | -10.19 | < 0.01 |
CAR | 1.02 ± 0.40 | 0.79 ± 0.38 | -3.88 | < 0.01 |
RDW (FL) | 17.64 ± 1.98 | 16.28 ± 1.26 | -4.72 | < 0.01 |
Total bilirubin (µmol/L) | 13.45 ± 2.51 | 13.75 ± 3.28 | 0.71 | 0.48 |
Albumin (g/L) | 42.08 ± 3.81 | 42.22 ± 2.71 | 0.25 | 0.80 |
Blood platelet count (109/L) | 167.13 ± 65.02 | 157.29 ± 40.59 | -1.04 | 0.30 |
WBC (109/L) | 7.48 ± 2.58 | 7.52 ± 3.12 | 0.08 | 0.93 |
ALT (U/L) | 47.88 ± 1.84 | 48.50 ± 1.59 | 2.40 | 0.017 |
AST (U/L) | 47.29 ± 1.25 | 47.14 ± 1.76 | -0.61 | 0.54 |
Surgical procedures | 0.01 | 0.94 | ||
Laparoscopy | 32 (61.50) | 118 (62.10) | ||
Open the abdomen | 20 (38.50) | 72 (37.90) | 0.01 | 0.93 |
Vascular invasion | 3.26 | 0.07 | ||
Yes | 24 (46.20) | 62 (32.60) | ||
No | 28 (53.80) | 128 (67.40) | 1.58 | 0.21 |
Tumor site | 1.01 | 0.32 | ||
Left | 30 (57.70) | 124 (65.30) | ||
Right | 22 (42.30) | 66 (34.70) | ||
Pathological type | 1.05 | 0.31 | ||
Adenocarcinoma | 48 (92.30) | 182 (95.80) | ||
Other | 4 (7.70) | 8 (4.20) | ||
Postoperative chemotherapy | 3.26 | 0.07 | ||
Yes | 24 (46.20) | 62 (32.60) | ||
No | 28 (53.80) | 128 (67.40) | ||
Preoperative CEA (μg/L) | 9.59 | < 0.01 | ||
< 5 | 21 (40.40) | 122 (64.20) | ||
≥ 5 | 31 (59.60) | 68 (35.80) | ||
Lymphatic node transfer | 4.90 | 0.03 | ||
Yes | 28 (53.80) | 70 (36.80) | ||
No | 24 (46.20) | 120 (63.20) |
- Citation: Cheng DX, Xu KD, Liu HB, Liu Y. Prognostic value of a nomogram model for postoperative liver metastasis of colon cancer. World J Gastrointest Surg 2024; 16(4): 1055-1065
- URL: https://www.wjgnet.com/1948-9366/full/v16/i4/1055.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i4.1055